Company intelligence
Caristo Diagnostics
Medical Device for Vascular Disease Diagnosis
About Caristo Diagnostics
Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions. Our Website: https://www.caristo.com Follow us on Twitter: https://twitter.com/CaristoHeart
Verified activity
Signals from Caristo Diagnostics
3 published signals
Research & Knowledge
Caristo Diagnostics announced that Dr. Eric Topol, MD is conducting a Ground Truths analysis and an upcoming September 9 podcast episode focusing on the FAI-Score biomarker and its role in coronary inflammation measurement.
Reported by Caristo Diagnostics
Presence & Recognition
Caristo Diagnostics employee Prof. Charalambos Antoniades MD PhD FRCP FMedSci delivered the ESC Paul Hugenholtz Lecture in Innovation at the ESC Congress.
Reported by Caristo Diagnostics
Research & Knowledge
Caristo Diagnostics reported that the Cari-Heart FAI-Score has superior and complementary predictive value for cardiac mortality beyond hsCRP, with very high prognostic performance for cardiac mortality and identifying high risk patients.
Reported by Caristo Diagnostics